Björne Håkan, Govoni Mirco, Törnberg Daniel C, Lundberg Jon O, Weitzberg Eddie
Department of Anesthesiology and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
Crit Care Med. 2005 Aug;33(8):1722-7. doi: 10.1097/01.ccm.0000171204.59502.aa.
Nitrite in saliva is reduced to nitric oxide (NO) in the acidic stomach, and this NO may serve gastroprotective functions. We studied intragastric NO levels in healthy controls and in intubated intensive care unit patients before and after supplementation with nitrite.
Prospective observational study involving patients and controls.
A mixed intensive care unit and a university laboratory.
Eight healthy volunteers and ten intubated, mechanically ventilated intensive care unit patients.
A tonometric catheter was first evaluated in vitro and then used for all NO measurements. In fasting controls, gastric NO levels were measured repeatedly during periods of saliva depletion and after an intragastric nitrite infusion. In patients, changes in levels of intragastric NO, nitrite in plasma and gastric juice, and S-nitrosothiols in gastric juice were measured in response to an intragastric nitrite infusion.
The tonometric catheter had a recovery of 80% with a high intraclass and interclass correlation. Median baseline NO levels in healthy volunteers were 21.6 ppm (interquartile range, 11.4-22.3 ppm) and decreased by 90% to 3.3 ppm (2.0-5.2 ppm) during 25-50 mins of saliva depletion. The NO level was restored by an intragastric nitrite infusion. Baseline NO levels in patients were almost abolished (0.1 ppm [0.07-0.4 ppm]) but increased rapidly to 124 ppm (range, 65-180 ppm) during intragastric nitrite infusion. Nitrite levels in plasma increased from 0.18 +/- 0.03 to 1.3 +/- 0.2 microM (p < .01), and levels of S-nitrosothiols in gastric juice increased from 0.12 +/- 0.09 to 6.7 +/- 1.8 microM.
Intragastric generation of NO requires continuous delivery of nitrite-containing saliva and is almost abolished in critically ill, intubated patients. Enteral supplementation with nitrite could however fully restore gastric NO levels. Future studies will reveal if low NO levels contribute to stress ulcers and gastric overgrowth of bacteria often seen in these patients and in turn if restoring gastric NO with nitrite could be a useful therapeutic approach.
唾液中的亚硝酸盐在酸性胃内被还原为一氧化氮(NO),这种NO可能具有胃保护功能。我们研究了健康对照者以及插管重症监护病房患者补充亚硝酸盐前后的胃内NO水平。
涉及患者和对照者的前瞻性观察性研究。
综合性重症监护病房和大学实验室。
8名健康志愿者和10名插管、机械通气的重症监护病房患者。
首先对张力测定导管进行体外评估,然后用于所有NO测量。在空腹对照者中,在唾液耗尽期间及胃内输注亚硝酸盐后反复测量胃内NO水平。在患者中,测量胃内输注亚硝酸盐后胃内NO水平、血浆和胃液中亚硝酸盐水平以及胃液中S-亚硝基硫醇水平的变化。
张力测定导管的回收率为80%,组内和组间相关性高。健康志愿者的中位基线NO水平为21.6 ppm(四分位间距,11.4 - 22.3 ppm),在唾液耗尽25 - 50分钟期间降至3.3 ppm(2.0 - 5.2 ppm),下降了90%。胃内输注亚硝酸盐后NO水平得以恢复。患者的基线NO水平几乎为零(0.1 ppm [0.07 - 0.4 ppm]),但在胃内输注亚硝酸盐期间迅速升至124 ppm(范围,65 - 180 ppm)。血浆中亚硝酸盐水平从0.18±0.03升至1.3±0.2微摩尔/升(p <.01),胃液中S-亚硝基硫醇水平从0.12±0.09升至6.7±1.8微摩尔/升。
胃内NO的生成需要持续输送含亚硝酸盐的唾液,在重症插管患者中几乎完全消失。然而,肠内补充亚硝酸盐可完全恢复胃内NO水平。未来的研究将揭示低NO水平是否导致这些患者中常见的应激性溃疡和胃细菌过度生长,以及反过来用亚硝酸盐恢复胃内NO是否可能是一种有用的治疗方法。